Liver Disease and Renal Function Monitoring

Introduction to Monitoring

• The American Association for the Study of Liver Diseases recognizes BUN as an important parameter to monitor in patients with liver disease, particularly those with ascites, as low BUN may indicate severe hepatic dysfunction with impaired urea synthesis 1
• The American College of Cardiology and the European Society of Cardiology recommend a comprehensive approach to heart failure management, including therapy optimization, dietary recommendations, and careful monitoring of patients 2, 3

Parameters for Monitoring

• The American College of Cardiology recommends judicious diuretic therapy with careful monitoring, and combination therapy with metolazone may be needed for resistant edema 2, 4
• Judicious diuresis with loop diuretics may be considered for overhydration, along with restriction of fluid intake and monitoring of daily weights and fluid balance, as recommended by relevant clinical guidelines 5
• Normal BUN levels typically range from 7-20 mg/dL (2.5-7.1 mmol/L), and the BUN:creatinine ratio can provide clues to underlying causes of BUN elevation, as noted by the American Journal of Kidney Diseases and National Kidney Foundation 5, 6, 7

Renal Function Assessment

• Cystatin C measurement may be used to estimate GFR, according to the American College of Physicians, with a strength of evidence level of high 8
• Direct GFR measurement with iothalamate or inulin clearance may be considered if clinical suspicion of renal dysfunction remains high, as recommended by the European Renal Association, with a strength of evidence level of low 8
• The American Geriatrics Society notes that lower muscle mass in elderly patients may affect the interpretation of creatinine levels, with a strength of evidence level of moderate 8
• The American College of Sports Medicine states that higher muscle mass and creatine supplementation in athletes/bodybuilders can lead to higher baseline creatinine, with a strength of evidence level of moderate 8

Monitoring Frequency

9, 10

Medication Management

• The National Comprehensive Cancer Network recommends avoiding nephrotoxic medications, particularly NSAIDs, in patients with any degree of renal dysfunction 11
• NSAIDs should be stopped immediately in patients with renal dysfunction to avoid medication-induced nephrotoxicity, as recommended by the European Journal of Heart Failure 12
• Medication doses should be adjusted based on renal function in renal failure patients, with consideration of potential interactions and nephrotoxic effects, as recommended by the National Kidney Foundation 13
• ACE inhibitors can cause increases in BUN and creatinine, especially in patients with severe heart failure, bilateral renal artery stenosis, or pre-existing renal impairment, and may require dose adjustment or discontinuation, as recommended by the American College of Cardiology 14
• The European Society of Cardiology recommends continuing ACEIs/ARBs unless creatinine increases >50% or to >3 mg/dL 15

Dietary Recommendations

• Consider sodium restriction (≤2 g/day) for heart failure patients 2
• Fluid restriction (1L/day) is recommended for euvolemic patients with Syndrome of Inappropriate ADH (SIADH) or hyponatremia, as per the Neurosurgery guidelines and the American Heart Association 16, 17

Nephrology Referral

• Considering nephrology referral if there is no improvement with initial management, progressive renal dysfunction, or need for potential renal replacement therapy, is crucial, as suggested by the American Society of Nephrology 18
• Early referral to nephrology should be considered for significantly elevated CK levels, signs of developing acute kidney injury, or need for potential renal replacement therapy, with modality selection based on patient's hemodynamic status, available resources, and expertise, as recommended by the National Kidney Foundation and Kidney Disease: Improving Global Outcomes (KDIGO) 19, 20, 21

Management of Hyponatremia

• For severe symptoms (seizures, altered mental status), 3% hypertonic saline is recommended, with a target correction of 6 mmol/L over 6 hours or until severe symptoms improve, as per the Neurosurgery guidelines 16
• The treatment of heart failure patients with hyponatremia should include fluid restriction (1L/day) and judicious diuresis with loop diuretics, while avoiding aggressive diuresis, which can worsen outcomes, as recommended by the Neurosurgery guidelines 16
• Patients with heart failure and hyponatremia should be monitored for signs of advanced heart failure, and the rate of correction of hyponatremia should not exceed 0.5 mmol/L/hr or 8 mmol/L/day for chronic hyponatremia, as recommended by the American Heart Association 17